Chief Development Officer Christopher Yea sold $905K of KalVista Pharmaceuticals, Inc.

Sold$905,225

$26.78Price

33,800Shares

−13%Stake

What KALV did after the filing

Prices for KALV after this filing aren't in yet.

Traded Wed, May 27. Filed Fri, May 29, 4:05 PM ET, after the close. Not investment advice.